0,723  0,005  5 Hydroxytryptamine release stimulant
0,662  0,004  Cholinergic
0,619  0,016  Aldehyde oxidase inhibitor
0,607  0,004  Sigma receptor agonist
0,606  0,008  Cardiodepressant
0,590  0,004  5 Hydroxytryptamine 7 antagonist
0,568  0,004  Acetylcholinesterase inhibitor
0,577  0,027  Antileukemic
0,556  0,017  Spasmolytic
0,530  0,024  Antidepressant
0,520  0,018  UGT1A9 substrate
0,513  0,023  CYP2D6 substrate
0,499  0,010  Sedative
0,484  0,004  Dopamine D2 agonist
0,515  0,045  Analgesic
0,491  0,032  Mood disorders treatment
0,490  0,037  Antineoplastic (colorectal cancer)
0,487  0,035  Antineoplastic (colon cancer)
0,464  0,014  Antineoplastic enhancer
0,452  0,004  Dopamine agonist
0,448  0,006  Pneumotoxic
0,473  0,032  Respiratory analeptic
0,444  0,005  Sigma receptor antagonist
0,444  0,005  Antitussive
0,440  0,004  Opioid kappa receptor antagonist
0,475  0,043  Antiprotozoal
0,477  0,049  Antineoplastic (lung cancer)
0,448  0,020  Hypoxia-inducible factor 1 alpha inhibitor
0,443  0,018  Dependence treatment
0,463  0,050  Transcription factor NF kappa B inhibitor
0,396  0,004  Opioid antagonist
0,471  0,083  Apoptosis agonist
0,428  0,042  Antiprotozoal (Plasmodium)
0,388  0,004  Dopamine D5 antagonist
0,391  0,009  5 Hydroxytryptamine 2B antagonist
0,442  0,068  Antineoplastic (breast cancer)
0,399  0,027  Tumour necrosis factor alpha release inhibitor
0,431  0,063  Antiparkinsonian
0,415  0,048  Prostate cancer treatment
0,364  0,005  Dopamine D1 antagonist
0,373  0,019  Muscle relaxant
0,356  0,004  Opioid mu receptor antagonist
0,351  0,008  Butyrylcholinesterase inhibitor
0,383  0,046  Antipsychotic
0,447  0,112  Antiinflammatory
0,349  0,014  Skeletal muscle relaxant
0,347  0,017  Tyrosine 3 hydroxylase inhibitor
0,388  0,062  Cognition disorders treatment
0,365  0,047  Analeptic
0,321  0,004  Opioid delta receptor antagonist
0,349  0,037  FMO3 substrate
0,317  0,010  Toxic, respiratory center
0,310  0,005  Antiprotozoal (Amoeba)
0,372  0,075  Immunosuppressant
0,311  0,015  5 Hydroxytryptamine 2 antagonist
0,318  0,042  Vasodilator
0,273  0,004  Antineoplastic alkaloid
0,331  0,064  Calcium channel activator
0,294  0,034  5 Hydroxytryptamine 1E antagonist
0,300  0,042  Cyclic AMP phosphodiesterase inhibitor
0,295  0,037  Antiparkinsonian, rigidity relieving
0,312  0,054  Antineoplastic (cervical cancer)
0,369  0,114  Alzheimer's disease treatment
0,377  0,126  Caspase 9 stimulant
0,331  0,082  Vasodilator, peripheral
0,334  0,084  CYP3A4 substrate
0,276  0,032  Antialcoholic
0,247  0,007  Analgesic, opioid
0,313  0,077  Apoptosis antagonist
0,231  0,005  Opioid mu receptor agonist
0,285  0,062  Flavin-containing monooxygenase substrate
0,231  0,011  Constipation treatment
0,322  0,109  CYP2C19 inhibitor
0,237  0,028  LDLR expression enhancer
0,235  0,027  5 Hydroxytryptamine antagonist
0,211  0,005  Opioid agonist
0,230  0,024  Neuropathy treatment
0,285  0,083  Anxiolytic
0,245  0,044  UGT2B7 substrate
0,228  0,029  Tubulin antagonist
0,274  0,078  CYP2C19 substrate
0,211  0,018  5 Hydroxytryptamine 2A antagonist
0,245  0,052  Anesthetic general
0,242  0,050  UGT1A1 substrate
0,208  0,016  Alpha 2c adrenoreceptor antagonist
0,313  0,122  TNF expression inhibitor
0,194  0,005  Opioid kappa receptor agonist
0,218  0,028  Antidiarrheal
0,213  0,028  UGT2B10 substrate
0,204  0,023  Alpha 2b adrenoreceptor antagonist
0,255  0,076  5 Hydroxytryptamine uptake stimulant
0,225  0,048  Male reproductive disfunction treatment
0,211  0,037  NOS3 expression enhancer
0,257  0,084  UGT2B4 substrate
0,192  0,019  Dopamine antagonist
0,212  0,040  VEGF expression inhibitor
0,213  0,044  UGT1A3 substrate
0,221  0,053  P-glycoprotein inhibitor
0,200  0,032  Cholinergic antagonist
0,179  0,013  Prolactin inhibitor
0,201  0,039  UGT2B9 substrate
0,256  0,094  Cardioprotectant
0,194  0,032  Acetylcholine antagonist
0,279  0,120  Stroke treatment
0,173  0,016  Acetylcholine nicotinic antagonist
0,220  0,066  Antiarrhythmic
0,162  0,014  5 Hydroxytryptamine 1F antagonist
0,153  0,005  Narcotic antagonist
0,179  0,031  Alpha adrenoreceptor antagonist
0,167  0,020  Dopamine D2 antagonist
0,189  0,044  Erectile dysfunction treatment
0,158  0,025  Alpha 2 adrenoreceptor antagonist
0,144  0,014  Tocolytic
0,182  0,053  Interleukin 6 antagonist
0,179  0,050  Antiparkinsonian, tremor relieving
0,177  0,053  UGT2B15 substrate
0,178  0,054  Uterine stimulant
0,176  0,054  Acetylcholine M1 receptor antagonist
0,161  0,040  Antiviral (Hepatitis B)
0,191  0,071  Hepatoprotectant
0,143  0,024  Alpha 2a adrenoreceptor antagonist
0,221  0,102  Antiprotozoal (Trypanosoma)
0,145  0,028  5 Hydroxytryptamine 2C antagonist
0,188  0,072  Nitric oxide antagonist
0,128  0,016  Neuronal nicotinic receptor antagonist
0,229  0,118  CYP1A2 substrate
0,178  0,069  UGT1A4 substrate
0,201  0,093  UGT1A6 substrate
0,260  0,153  Antipruritic, allergic
0,191  0,085  Neurotrophic factor enhancer
0,228  0,122  NOS3 expression inhibitor
0,109  0,004  Prolactin release inhibitor
0,137  0,032  Alpha 1 adrenoreceptor antagonist
0,205  0,102  Antineoplastic (non-small cell lung cancer)
0,159  0,062  Lipid peroxidase inhibitor
0,238  0,141  FMO1 substrate
0,250  0,155  Histamine release inhibitor
0,246  0,153  CYP2C9 substrate
0,195  0,102  Free radical scavenger
0,185  0,093  Antimitotic
0,235  0,145  Sodium/bile acid cotransporter inhibitor
0,146  0,056  Cocaine dependence treatment
0,111  0,022  Dopamine D3 antagonist
0,137  0,053  Acetylcholine muscarinic antagonist
0,176  0,095  Psychostimulant
0,124  0,044  Antiadrenergic
0,171  0,093  Antimigraine
0,145  0,068  Antineoplastic (squamous cell carcinoma)
0,190  0,115  Cardiovascular analeptic
0,145  0,072  Protein kinase stimulant
0,193  0,119  Antioxidant
0,077  0,004  Dopamine D1 agonist
0,112  0,040  Calcium antagonist
0,100  0,029  Acetylcholine M4 receptor antagonist
0,102  0,031  5 Hydroxytryptamine 1A antagonist
0,103  0,035  Alpha 1a adrenoreceptor antagonist
0,165  0,097  UDP-glucuronosyltransferase substrate
0,103  0,036  5 Hydroxytryptamine 1 antagonist
0,128  0,061  Anesthetic local
0,136  0,070  Anesthetic
0,181  0,117  NOS2 expression inhibitor
0,070  0,008  Opioid delta receptor agonist
0,126  0,066  M18 aspartyl aminopeptidase inhibitor
0,084  0,023  Uterine relaxant
0,212  0,153  Antiallergic
0,114  0,055  Electron transport complex I inhibitor
0,077  0,018  Nicotinic receptor alpha7 subunit antagonist
0,116  0,058  Myasthenia Gravis treatment
0,189  0,132  Radioprotector
0,106  0,050  UGT2B11 substrate
0,142  0,087  Antinephritic
0,138  0,084  Antidote
0,061  0,008  Sigma 2 receptor antagonist
0,137  0,084  Genotoxic
0,075  0,027  5 Hydroxytryptamine 5A antagonist
0,070  0,022  Lipocortins synthesis agonist
0,101  0,053  Adrenaline antagonist
0,078  0,030  Beta tubulin antagonist
0,067  0,020  5 Hydroxytryptamine 1B agonist
0,068  0,021  5 Hydroxytryptamine 7 agonist
0,102  0,055  Tourette's syndrome treatment
0,109  0,063  Choleretic
0,183  0,137  Superoxide dismutase inhibitor
0,143  0,097  Prostate disorders treatment
0,053  0,010  Sigma 1 receptor antagonist
0,157  0,114  Abortion inducer
0,063  0,020  Nicotinic receptor alpha4 subunit antagonist
0,067  0,028  5 Hydroxytryptamine 5 antagonist
0,146  0,108  Aldehyde oxidase substrate
0,047  0,010  ATM kinase inhibitor
0,102  0,067  Expectorant
0,119  0,087  Toll-Like receptor 9 antagonist
0,123  0,092  Antieczematic
0,160  0,131  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,115  0,088  Antiviral (Papilloma)
0,142  0,114  Sleep disorders treatment
0,141  0,117  Platelet adhesion inhibitor
0,069  0,045  Acetylcholine M5 receptor agonist
0,066  0,043  5 Hydroxytryptamine 1D antagonist
0,117  0,095  Antimutagenic
0,076  0,054  Nicotinic alpha4beta2 receptor antagonist
0,088  0,068  Breast cancer-resistant protein inhibitor
0,140  0,121  Lipocortins synthesis antagonist
0,059  0,041  Alpha 1d adrenoreceptor antagonist
0,080  0,063  Antiprotozoal activity enhancer
0,063  0,047  5 Hydroxytryptamine 1B antagonist
0,077  0,061  Antidote, organophosphates
0,039  0,025  Oxytocin antagonist
0,051  0,037  5 Hydroxytryptamine 2 agonist
0,056  0,042  Dopamine uptake inhibitor
0,052  0,039  Nicotinic alpha3beta2 receptor antagonist
0,085  0,072  Restless leg syndrome treatment
0,068  0,055  Alpha 1b adrenoreceptor antagonist
0,169  0,156  Antihypotensive
0,019  0,007  NMDA receptor phencyclidine site antagonist
0,037  0,030  Vesicle monoamine transporter inhibitor
0,052  0,047  Dopamine D4 antagonist
0,179  0,175  CYP2D6 inhibitor
0,162  0,158  Antineoplastic (ovarian cancer)
0,097  0,095  Acetylcholine release stimulant

